A Study Assessing the Safety, Tolerability, and Efficacy of RO7171009 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Conditions:   Macular Degeneration, Age-Related;   Geographic Atrophy
Interventions:   Drug: RO7171009;   Drug: Sham Control
Sponsor:   Genentech, Inc.
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days